Display options
Cite
Bae JS, Oh AR, Cha JY. Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs. J Lifestyle Med. 2013;3(1):19-25
Bae, J. S., Oh, A. R., & Cha, J. Y. (2013). Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs. Journal of lifestyle medicine, 3(1), 19-25.
Bae, Jin-Sik, et al. "Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs." Journal of lifestyle medicine vol. 3,1 (2013): 19-25.
Bae JS, Oh AR, Cha JY. Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs. J Lifestyle Med. 2013 Mar;3(1):19-25. Epub 2013 Mar 31. PMID: 26064833; PMCID: PMC4390754.
Copy Download .nbib Format: NLM
Share it on

J Lifestyle Med. 2013 Mar;3(1):19-25. Epub 2013 Mar 31.

Regulation of Cholesterol Metabolism in Liver: Link to NAFLD and Impact of n-3 PUFAs.

Journal of lifestyle medicine

Jin-Sik Bae, Ah-Reum Oh, Ji-Young Cha

Affiliations

  1. Laboratory of Cell Metabolism and Gene Regulation, Lee Gil Ya Cancer and Diabetes Institute, Gachon University, Incheon, Korea.

PMID: 26064833 PMCID: PMC4390754

Abstract

Non-alcoholic fatty liver disease (NAFLD) is one of the most common causes of chronic liver disease that affects one-third of adults in westernized countries. NAFLD represents a wide spectrum of hepatic alterations, ranging from simple triglyceride accumulation in the liver to steatohepatitis. Several pharmaceutical approaches to NAFLD management have been examined, but no particular treatment has been considered both safe and highly effective. Growing evidence reveal that supplemental fish oil, seal oil and purified n-3 fatty acids can reduce hepatic lipid content in NAFLD through extensive regulation by inhibiting lipogenesis, promoting fatty acid oxidation and suppressing inflammatory responses. Recently, the fat-1 transgenic mice capable of converting n-6 to n-3 polyunsaturated fatty acids (PUFAs) have been used to examine the effects of endogenous n-3 PUFAs on NAFLD. The increased n-3 PUFAs in fat-1 transgenic mice reduced diet-induced hyperlipidemia and fatty liver through induction of CYP7A1 expression and activation of cholesterol catabolism to bile acid. This article introduces the n-3 PUFAs, and addresses the evidence and mechanisms by which endogenously synthesized n-3 PUFAs or increased dietary n-3 PUFAs may ameliorate NAFLD.

Keywords: Cholesterol metabolism; Hepatic steatosis; Lipid metabolism; Non-alcoholic fatty liver disease; n-3 polyunsaturated fatty acids

References

  1. J Neurochem. 2008 Apr;105(2):380-8 - PubMed
  2. PLoS One. 2011;6(8):e23365 - PubMed
  3. J Nutr Biochem. 2008 Sep;19(9):567-76 - PubMed
  4. Chem Phys Lipids. 2008 May;153(1):3-13 - PubMed
  5. Cancer Res. 2008 May 15;68(10):3985-91 - PubMed
  6. Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1918-25 - PubMed
  7. Curr Opin Lipidol. 2008 Jun;19(3):242-7 - PubMed
  8. J Hepatol. 2009 Mar;50(3):562-71 - PubMed
  9. J Cell Mol Med. 2009 Aug;13(8B):1833-44 - PubMed
  10. Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13656-61 - PubMed
  11. Hepatology. 2010 Aug;52(2):678-90 - PubMed
  12. Am J Pathol. 2006 Sep;169(3):846-60 - PubMed
  13. J Hepatol. 2007 Nov;47(5):711-7 - PubMed
  14. Lipids Health Dis. 2009 Dec 30;8:61 - PubMed
  15. Obesity (Silver Spring). 2007 Jan;15(1):24-31 - PubMed
  16. Int J Obes (Lond). 2006 Oct;30(10):1535-44 - PubMed
  17. Clin Sci (Lond). 2004 Jun;106(6):635-43 - PubMed
  18. Hepatology. 2003 Dec;38(6):1529-39 - PubMed
  19. J Lipid Res. 2009 Oct;50(10 ):1955-66 - PubMed
  20. Dig Dis Sci. 2010 Mar;55(3):631-41 - PubMed
  21. Ann Nutr Metab. 2009;55(1-3):8-43 - PubMed
  22. Transplantation. 2005 Mar 15;79(5):606-8 - PubMed
  23. J Nutr. 2002 Jan;132(1):88-94 - PubMed
  24. Am J Respir Crit Care Med. 2009 Mar 15;179(6):474-83 - PubMed
  25. Obes Rev. 2009 Nov;10(6):648-59 - PubMed
  26. Hepatology. 2007 Oct;46(4):1081-90 - PubMed
  27. Circulation. 2002 Nov 19;106(21):2747-57 - PubMed
  28. Biochem Biophys Res Commun. 2009 Apr 24;382(1):51-6 - PubMed
  29. Am J Clin Nutr. 2008 Feb;87(2):347-53 - PubMed
  30. Hepatology. 2007 Apr;45(4):855-63 - PubMed
  31. Clin Nutr. 2011 Feb;30(1):6-19 - PubMed
  32. Diabetes. 2010 Dec;59(12):3066-73 - PubMed
  33. Lipids Health Dis. 2012 Oct 31;11:148 - PubMed
  34. Gastroenterology. 1998 Apr;114(4):842-5 - PubMed
  35. Prostaglandins Leukot Essent Fatty Acids. 2000 Sep;63(3):119-21 - PubMed
  36. Prog Lipid Res. 2009 Jan;48(1):1-26 - PubMed
  37. Hepatology. 2004 Mar;39(3):608-16 - PubMed
  38. Oxid Med Cell Longev. 2009 Nov-Dec;2(5):307-16 - PubMed
  39. Biochim Biophys Acta. 2009 Nov;1792(11):1080-6 - PubMed
  40. Biochem Pharmacol. 2012 Nov 15;84(10):1359-65 - PubMed
  41. Biochem Pharmacol. 2002 Jun 15;63(12):2075-80 - PubMed
  42. J Mol Endocrinol. 2006 Jun;36(3):485-501 - PubMed
  43. Biochem Biophys Res Commun. 2006 Oct 27;349(3):925-30 - PubMed
  44. Nature. 2004 Feb 5;427(6974):504 - PubMed
  45. FASEB J. 2009 Jun;23(6):1946-57 - PubMed
  46. Science. 2011 Jun 24;332(6037):1519-23 - PubMed
  47. Platelets. 2009 Feb;20(1):16-22 - PubMed

Publication Types